Maintenance Infusion of 3% Hypertonic Saline for ICP Control
For maintenance infusion after an initial 5 mL/kg bolus, administer 3% hypertonic saline at 1.5 mL/kg/hour as continuous infusion, targeting a serum sodium concentration of 145-155 mmol/L. 1, 2
Dosing Strategy
The evidence supports using 3% hypertonic saline as a continuous infusion at 1.5 mL/kg/hour for maintenance therapy in patients with elevated intracranial pressure 2. This approach has been studied in 107 patients with traumatic brain injury, stroke, and subarachnoid hemorrhage, demonstrating effectiveness in ICP control.
Target Parameters
- Target serum sodium: 145-155 mmol/L 1, 2
- When sodium exceeds 155 mmol/L, switch to 2% saline to wean or maintain levels 2
- Do not re-administer bolus doses until serum sodium falls below 155 mmol/L 1
Monitoring Requirements
Critical monitoring parameters include:
- Serum sodium within 6 hours of bolus administration 1
- Continuous sodium monitoring during infusion therapy to prevent severe hypernatremia
- Mean treatment duration in pediatric studies was 7.6 days, with sodium levels reaching 170.7 mmol/L without adverse effects 1
Safety Profile
The continuous infusion approach is well-tolerated when properly monitored 2. In a study of 107 patients receiving continuous 3% hypertonic saline:
- Moderate hypernatremia (Na >155 mmol/L) occurred more frequently than with normal saline
- No acute renal failure was observed despite elevated BUN/creatinine in some patients
- No increased infection rates, DVT, or dural thrombosis compared to normal saline 2
Important Caveats
While hypernatremia is common with continuous infusion, no evidence of osmotic demyelination syndrome has been documented even with sodium levels reaching 170 mmol/L in pediatric patients 1. The highest recorded sodium in a survivor was 169 mmol/L, with most patients maintaining levels below 155 mmol/L 1.
Duration of Effect
Bolus dosing provides 3-4 hours of ICP reduction (approximately 5-6 mmHg decrease), which is why continuous infusion is preferred for sustained control 3. The "53-53" rule applies to boluses: 5 mL/kg of 3% HTS decreases ICP by at least 5 mmHg for 3 hours 3.
Clinical Context
3% hypertonic saline is effective at reducing raised intracranial pressure (Grade A evidence) but does not improve neurological outcomes or survival 1. It should be used instead of, not in conjunction with, mannitol for ICP management 1. The lack of standardized protocols across institutions remains a limitation, but the 1.5 mL/kg/hour continuous infusion rate represents the most commonly studied and safest approach 1, 2.